- Home
- LDI vs EBS Comparison
LDI vs EBS Comparison
Compare LDI & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LDI | EBS |
|---|---|---|
| Founded | 2010 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 587.6M | 663.3M |
| IPO Year | 2021 | 2006 |
Fundamental Metrics
Financial Performance| Metric | LDI | EBS |
|---|---|---|
| Price | $2.17 | $11.30 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $3.00 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 4.8M | 961.3K |
| Earning Date | 03-10-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.35 |
| Revenue | ★ $1,095,780,000.00 | $788,900,000.00 |
| Revenue This Year | $28.65 | N/A |
| Revenue Next Year | $20.19 | $15.21 |
| P/E Ratio | ★ N/A | $8.40 |
| Revenue Growth | ★ 10.74 | N/A |
| 52 Week Low | $1.01 | $4.02 |
| 52 Week High | $5.05 | $14.06 |
Technical Indicators
Market Signals| Indicator | LDI | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 38.83 | 43.73 |
| Support Level | $2.55 | $11.53 |
| Resistance Level | $2.89 | $12.31 |
| Average True Range (ATR) | 0.20 | 0.72 |
| MACD | -0.05 | -0.08 |
| Stochastic Oscillator | 2.23 | 34.11 |
Price Performance
Historical ComparisonAbout LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.